Candesartan Cilexetil - CAS 145040-37-5
Catalog number: 145040-37-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C33H34N6O6
Molecular Weight:
610.66
COA:
Inquire
Targets:
Angiotensin Receptor
Description:
Candesartan blocks the effects of angiotensin II at the angiotensin II type 1 (AT1) receptor. Candesartan cilexetil is a prodrug that is activated to candesartan by ester hydrolysis during gastrointestinal absorption.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
TCV-116
MSDS:
Inquire
1. Systematic development of novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with enhanced biopharmaceutical performance
Gajanand Sharma, Sarwar Beg, Kaushik Thanki, Sanyog Jain,* Bhupinder Singh*. RSC Adv.,2015, 5,71500–71513
Candesartan cilexetil is popularly recommended for the treatment and management of hypertension. However, its therapeutic efficacy gets markedly reduced owing to low oral bioavailability as a function of poor solubility, extensive hepatic first-pass effect and high P-glycoprotein (P-gp) efflux. Several formulation strategies including solid dispersions, cosolvates, nclusion complexes and nanosuspensions have been under-taken to enhance the oral bioavailability of candesartan cilexetil. However, none of these formulations are found to be highly effective to address the low oral bioavailability issues, as these tend to deal with the poor solubility issue only. Lately, self-nanoemulsifying drug delivery systems (SNEDDS) have been extensively investigated for augmenting the oral absorption of highly lipophilic drugs owing to their inherent potential to improve drug solubility and permeability, and eventually its oral bioavailability.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Angiotensin Receptor Products


CAS 144689-63-4 Olmesartan Medoxomil

Olmesartan Medoxomil
(CAS: 144689-63-4)

Olmesartan Medoxomil is a compound which is hydrolyzed to olmesartan that is a selective AT1 subtype angiotensin II receptor antagonist.

CAS 136676-91-0 PD-123319 TFA salt

PD-123319 TFA salt
(CAS: 136676-91-0)

The ditrifluoroacetate salt form of PD-123319, a nonpeptide AT2R antagonist, could have potential effect against hypertension. It has already been discontinued ...

CAS 51833-78-4 Angiotensin I/II (1-7)

Angiotensin I/II (1-7)
(CAS: 51833-78-4)

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor, inducing vasorelaxation through release of NO and prostaglandins.

CAS 114798-26-4 Losartan

Losartan
(CAS: 114798-26-4)

Losartan, an antagonist of angiotensin II receptor, could be effective in the treatment of hypertensive. IC50: 20nM.

AVE 0991 sodium salt
(CAS: 306288-04-0)

AVE 0991 sodium salt, is an agonist of nonpeptide Ang-(1-7) receptor Mas that has potential as a cardiovascular drug.

CAS 145040-37-5 Candesartan Cilexetil

Candesartan Cilexetil
(CAS: 145040-37-5)

Candesartan blocks the effects of angiotensin II at the angiotensin II type 1 (AT1) receptor. Candesartan cilexetil is a prodrug that is activated to candesarta...

CAS 141887-34-5 A81988

A81988
(CAS: 141887-34-5)

A81988 is a potent, orally active angiotensin I1 antagonist with a long duration of action whose pharmacological profile has established it as an important tool...

CAS 145733-36-4 Tasosartan

Tasosartan
(CAS: 145733-36-4)

Tasosartan, a pyrido-pyrimidin derivative, has been found to be an angiotensin II receptor antagonist that could have probable effect against hypertension. It h...

CAS 863031-21-4 Azilsartan Medoxomil

Azilsartan Medoxomil
(CAS: 863031-21-4)

Azilsartan Medoxomil is a potent angiotensin II type 1 (AT1) receptor antagonist that inhibits the RAAS, with an IC50 of 2.6 nM. It exhibits more than 10,000-fo...

Tranilast Sodium
(CAS: 104931-56-8)

Tranilast, an allergic media blocker, is effective for the treatment of asthma and is also used to treat asthma, allergic rhinitis and other allergic disorders.

CAS 130663-39-7 PD123319

PD123319
(CAS: 130663-39-7)

PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.

CAS 936623-90-4 LCZ696

LCZ696
(CAS: 936623-90-4)

LCZ696 is a potent ARNi inhibitor and an investigational drug to treat heart failure. Chemically, LCZ696 is a mixture of valsartan and sacubitril in a 1:1 mol...

PD 123177
(CAS: 114785-12-5)

PD 123177 is a Nonpeptide angiotensin type 2 receptor inhibitor. In Dec 1995, Preclinical development of it for cardiovascular disorders was began in USA.

Sacubitrilat
(CAS: 149709-44-4)

Sacubitrilat is one of the impurities of Sacubitril which has been found to be an endopeptidase inhibitor and be effective in the treatment of hypertension and ...

CAS 156001-18-2 Embusartan

Embusartan
(CAS: 156001-18-2)

Embusartan, an oxopyridine derivative, has been found to be an angiotensin II receptor antagonist that was once studied against hypertension by Bayer.

CAS 144689-24-7 Olmesartan

Olmesartan
(CAS: 144689-24-7)

Olmesartan, a synthetic imidazole derivative, is a specific angiotensin II type 1 (AT1) receptor antagonist with antihypertensive effect. hAT1 receptors: IC50 =...

CAS 124750-99-8 Losartan Potassium (DuP 753)

Losartan Potassium (DuP 753)
(CAS: 124750-99-8)

Losartan is an angiotensin II receptor antagonist that competes with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM. It promotes vasodilatati...

CAS 144143-96-4 Eprosartan Mesylate

Eprosartan Mesylate
(CAS: 144143-96-4)

Eprosartan is a nonpeptide angiotensin II receptor antagonist, [3H]-eprosartan binds to the AT1 receptor with KD of 0.83 nM in rat vascular smooth muscle cells.

CAS 154512-46-6 L162441

L162441
(CAS: 154512-46-6)

An antagonist of Angiotensin type 1 receptor

CAS 139481-59-7 Candesartan

Candesartan
(CAS: 139481-59-7)

Candesartan (10 mg/kg) inhibits the growth of engrafted tumors and reduces the microvessel density and VEGF expression in a mouse KU-19-19 xenograft model

Chemical Structure

CAS 145040-37-5 Candesartan Cilexetil

Quick Inquiry

Verification code

Featured Items